首页 | 本学科首页   官方微博 | 高级检索  
     

联合应用阿托伐他汀和二甲双胍治疗混合性高脂血症的疗效及安全性观察
引用本文:林雪芳,李平. 联合应用阿托伐他汀和二甲双胍治疗混合性高脂血症的疗效及安全性观察[J]. 海南医学, 2008, 19(6): 7-8
作者姓名:林雪芳  李平
作者单位:广西医科大学第六附属医院心内科,广西,玉林,537000;广西医科大学第六附属医院心内科,广西,玉林,537000
摘    要:目的观察联合应用阿托伐他汀和二甲双胍治疗混合性高脂血症的疗效及安全性。方法选择混合性高脂血症患者168例,随机分为二组:(A)阿托伐他汀组80例,(B)阿托伐他汀和二甲双胍联合治疗组88例。观察治疗前和治疗后12w的TC、TG、LDL-C及HDL-C的血清浓度变化。结果联合治疗组治疗后TC、LDL-C、TG三项较单药治疗组更易达标,两组间有显著性差异(P<0.01)。结论对于混合性高脂血症患者,阿托伐他汀联合二甲双胍治疗较阿托伐他汀单药治疗能更有效地使TC、LDL-C、TG达标,而且联合应用治疗混合性高脂血症价廉、安全、有效。

关 键 词:阿托伐他汀  二甲双胍  混合性高脂血症
文章编号:1003-6350(2008)06-007-02
修稿时间:2008-02-25

The effects and safety of atorvastatin combines with dimethyl biguanide in patients with combined hyperlipidemia
LIN Xue-fang,LI Ping. The effects and safety of atorvastatin combines with dimethyl biguanide in patients with combined hyperlipidemia[J]. Hainan Medical Journal, 2008, 19(6): 7-8
Authors:LIN Xue-fang  LI Ping
Abstract:Objective To investigate the effects and safety of atorvastatin combines with dimethyl biguanide in patients with combined hyperlipidemia. Methods 168 patients with combined hyperlipidemia were randomized into two groups: group A and group B.Group A (80 cases)were administered atorvastatin 20mg/d,while group B (88 cases) 20mg/d and dimethyl biguanide 0.25g, 3time/d. The total period of treatment was 12 weeks. Results In both of two groups, serum total cholesterol (TC), low density lipoprotein cholesterol(LDL-C) and lipoprotein cholesterol (TG) were decreased significantly, however patients in group B was better than group A (P<0.01). Conclusion In patients with combined hyperlipidemia,the efficacy of serum TC, LDL-C and TG decreased by giving atorvastatin 20mg/d and dimethyl biguanide 0.25g, 3 time/d was better than atorvastatin 20mg/d. No serious side effects were found in both two groups.
Keywords:Atorvastatin  Dimethyl biguanide  Combined hyperlipidemia
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号